Literature DB >> 20089641

Dendritic cell migration limits the duration of CD8+ T-cell priming to peripheral viral antigen.

Amanda M Schell1, Erica L Granger, Frank Koczot, Matthew A Fischer, Christopher C Norbury.   

Abstract

CD8(+) T cells (T(CD8(+))) play a crucial role in immunity to viruses. Antiviral T(CD8(+)) are initially activated by recognition of major histocompatibility complex (MHC) class I-peptide complexes on the surface of professional antigen-presenting cells (pAPC). Migration of pAPC from the site of infection to secondary lymphoid organs is likely required during a natural infection. Migrating pAPC can be directly infected with virus or may internalize antigen derived from virus-infected cells. The use of experimental virus infections to assess the requirement for pAPC migration in initiation of T(CD8(+)) responses has proven difficult to interpret because injected virus can readily drain to secondary lymphoid organs without the need for cell-mediated transport. To overcome this ambiguity, we examined the generation of antigen-specific T(CD8(+)) after immunization with recombinant adenoviruses that express antigen driven by skin-specific or ubiquitous promoters. We show that the induction of T(CD8(+)) in response to tissue-targeted antigen is less efficient than the response to ubiquitously expressed antigen and that the resulting T(CD8(+)) fail to clear all target cells pulsed with the antigenic peptide. This failure to prime a fully functional T(CD8(+)) response results from a reduced period of priming to peripherally expressed antigen versus ubiquitously expressed antigen and correlated with a brief burst of pAPC migration from the skin, a requirement for induction of the response to peripheral antigen. These results indicate that a reduced duration of pAPC migration after virus infection likely reduces the amplitude of the T(CD8(+)) response, allowing persistence of the peripheral virus.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20089641      PMCID: PMC2838146          DOI: 10.1128/JVI.01975-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

1.  Cutting edge: recombinant adenoviruses induce CD8 T cell responses to an inserted protein whose expression is limited to nonimmune cells.

Authors:  S A Prasad; C C Norbury; W Chen; J R Bennink; J W Yewdell
Journal:  J Immunol       Date:  2001-04-15       Impact factor: 5.422

2.  Naïve CTLs require a single brief period of antigenic stimulation for clonal expansion and differentiation.

Authors:  M J van Stipdonk; E E Lemmens; S P Schoenberger
Journal:  Nat Immunol       Date:  2001-05       Impact factor: 25.606

3.  Memory CD8+ T cell differentiation: initial antigen encounter triggers a developmental program in naïve cells.

Authors:  S M Kaech; R Ahmed
Journal:  Nat Immunol       Date:  2001-05       Impact factor: 25.606

4.  Visualizing priming of virus-specific CD8+ T cells by infected dendritic cells in vivo.

Authors:  Christopher C Norbury; Daniela Malide; James S Gibbs; Jack R Bennink; Jonathan W Yewdell
Journal:  Nat Immunol       Date:  2002-02-04       Impact factor: 25.606

Review 5.  Immune evasion in human papillomavirus-associated cervical cancer.

Authors:  Robert W Tindle
Journal:  Nat Rev Cancer       Date:  2002-01       Impact factor: 60.716

6.  Cross-presentation of viral and self antigens by skin-derived CD103+ dendritic cells.

Authors:  Sammy Bedoui; Paul G Whitney; Jason Waithman; Liv Eidsmo; Linda Wakim; Irina Caminschi; Rhys S Allan; Magdalena Wojtasiak; Ken Shortman; Francis R Carbone; Andrew G Brooks; William R Heath
Journal:  Nat Immunol       Date:  2009-04-06       Impact factor: 25.606

Review 7.  Interaction of large DNA viruses with dendritic cells.

Authors:  L Jenne; P Thumann; A Steinkasserer
Journal:  Immunobiology       Date:  2001-12       Impact factor: 3.144

8.  Rapid cytotoxic T lymphocyte activation occurs in the draining lymph nodes after cutaneous herpes simplex virus infection as a result of early antigen presentation and not the presence of virus.

Authors:  Scott N Mueller; Claerwen M Jones; Chris M Smith; William R Heath; Francis R Carbone
Journal:  J Exp Med       Date:  2002-03-04       Impact factor: 14.307

9.  Lymph-borne chemokines and other low molecular weight molecules reach high endothelial venules via specialized conduits while a functional barrier limits access to the lymphocyte microenvironments in lymph node cortex.

Authors:  J E Gretz; C C Norbury; A O Anderson; A E Proudfoot; S Shaw
Journal:  J Exp Med       Date:  2000-11-20       Impact factor: 14.307

10.  Uncoupling of proliferative potential and gain of effector function by CD8(+) T cells responding to self-antigens.

Authors:  Javier Hernández; Sandra Aung; Kristi Marquardt; Linda A Sherman
Journal:  J Exp Med       Date:  2002-08-05       Impact factor: 14.307

View more
  4 in total

1.  Prolonged antigen presentation following an acute virus infection requires direct and then cross-presentation.

Authors:  Erica L Heipertz; Michael L Davies; Eugene Lin; Christopher C Norbury
Journal:  J Immunol       Date:  2014-09-15       Impact factor: 5.422

2.  A systemic macrophage response is required to contain a peripheral poxvirus infection.

Authors:  Michael L Davies; Nikhil J Parekh; Lauren W Kaminsky; Chetna Soni; Irene E Reider; Tracy E Krouse; Matthew A Fischer; Nico van Rooijen; Ziaur S M Rahman; Christopher C Norbury
Journal:  PLoS Pathog       Date:  2017-06-14       Impact factor: 6.823

3.  T cells loaded with magnetic nanoparticles are retained in peripheral lymph nodes by the application of a magnetic field.

Authors:  Laura Sanz-Ortega; José M Rojas; Ana Marcos; Yadileiny Portilla; Jens V Stein; Domingo F Barber
Journal:  J Nanobiotechnology       Date:  2019-01-22       Impact factor: 10.435

4.  Dynamic metabolic reprogramming in dendritic cells: An early response to influenza infection that is essential for effector function.

Authors:  Svetlana Rezinciuc; Lavanya Bezavada; Azadeh Bahadoran; Susu Duan; Ruoning Wang; Daniel Lopez-Ferrer; David Finkelstein; Maureen A McGargill; Douglas R Green; Ljiljana Pasa-Tolic; Heather S Smallwood
Journal:  PLoS Pathog       Date:  2020-10-26       Impact factor: 6.823

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.